Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Related Posts
Bowlero to Rebrand to Lucky Strike as It Buys More Entertainment Venues
Bowlero is formally rebranding to Lucky Strike Entertainment as it expands into family entertainment centers and water parks.
Macy’s Probe Found Employee Acted Alone in $151 Million Accounting Scandal
Macy’s has completed its investigation into accounting problems and found that a single employee’s mistake and coverup created $151 million in false bookkeeping entries.
Edgar Bronfman Prepares Bid for Paramount and Its Parent National Amusements
The bid would mark the latest twist in one of the messiest media mergers in recent history.